1. Home
  2. TENX vs UGRO Comparison

TENX vs UGRO Comparison

Compare TENX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • UGRO
  • Stock Information
  • Founded
  • TENX 1967
  • UGRO 2014
  • Country
  • TENX United States
  • UGRO United States
  • Employees
  • TENX N/A
  • UGRO N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • TENX Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • TENX 11.4M
  • UGRO 15.8M
  • IPO Year
  • TENX N/A
  • UGRO N/A
  • Fundamental
  • Price
  • TENX $3.34
  • UGRO $1.48
  • Analyst Decision
  • TENX Strong Buy
  • UGRO Strong Buy
  • Analyst Count
  • TENX 2
  • UGRO 2
  • Target Price
  • TENX $30.00
  • UGRO $5.63
  • AVG Volume (30 Days)
  • TENX 30.1K
  • UGRO 19.6K
  • Earning Date
  • TENX 11-11-2024
  • UGRO 11-07-2024
  • Dividend Yield
  • TENX N/A
  • UGRO N/A
  • EPS Growth
  • TENX N/A
  • UGRO N/A
  • EPS
  • TENX N/A
  • UGRO N/A
  • Revenue
  • TENX N/A
  • UGRO $70,320,066.00
  • Revenue This Year
  • TENX N/A
  • UGRO $14.76
  • Revenue Next Year
  • TENX N/A
  • UGRO $21.29
  • P/E Ratio
  • TENX N/A
  • UGRO N/A
  • Revenue Growth
  • TENX N/A
  • UGRO 12.08
  • 52 Week Low
  • TENX $2.77
  • UGRO $1.02
  • 52 Week High
  • TENX $61.20
  • UGRO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • TENX 37.74
  • UGRO 59.20
  • Support Level
  • TENX $3.28
  • UGRO $1.27
  • Resistance Level
  • TENX $3.55
  • UGRO $1.55
  • Average True Range (ATR)
  • TENX 0.22
  • UGRO 0.09
  • MACD
  • TENX -0.03
  • UGRO 0.02
  • Stochastic Oscillator
  • TENX 8.96
  • UGRO 78.79

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: